Haloom Rafehi
Impact in
- Rehabilitation top 10%
- Wound Healing and Treatments
-
- Congenital heart defects research
- Histone Deacetylase Inhibitors Research
- Epigenetics and DNA Methylation
- RNA modifications and cancer
Papers in
-
- Histone Deacetylase Inhibitors Research 8
- Epigenetics and DNA Methylation 4
- Protein Degradation and Inhibitors 3
- Genomics and Chromatin Dynamics 3
- RNA modifications and cancer 2
- DNA Repair Mechanisms 2
-
- Genetic Neurodegenerative Diseases 4
- Co-authors
- Assam El‐Osta (21 shared papers)Tom C. Karagiannis (13 shared papers)Katherine Ververis (5 shared papers)Mark Ziemann (14 shared papers)Christian Orlowski (2 shared papers)Antony Kaspi (5 shared papers)Jenny Y. Y. Ooi (5 shared papers)Xiao‐Jun Du (4 shared papers)
In The Last Decade
Haloom Rafehi
32 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 103
- Rehabilitation 50
- Molecular Biology 543
- Cancer Research 98
- Biochemistry 39
- Endocrinology, Diabetes and Metabolism 89
Countries citing papers authored by Haloom Rafehi
This map shows the geographic impact of Haloom Rafehi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haloom Rafehi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haloom Rafehi more than expected).
Fields of papers citing papers by Haloom Rafehi
This network shows the impact of papers produced by Haloom Rafehi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haloom Rafehi. The network helps show where Haloom Rafehi may publish in the future.
Co-authors
The 25 scholars most cited alongside Haloom Rafehi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 189 | |
| 2 | 2011 | 177 | |
| 3 | 2015 | 111 | |
| 4 | 2014 | 66 | |
| 5 | 2011 | 53 | |
| 6 | 2010 | 48 | |
| 7 | 2018 | 47 | |
| 8 | 2012 | 45 | |
| 9 | 2011 | 38 | |
| 10 | 2011 | 35 | |
| 11 | 2012 | 30 | |
| 12 | 2017 | 29 | |
| 13 | 2020 | 22 | |
| 14 | 2017 | 19 | |
| 15 | 2017 | 15 | |
| 16 | 2016 | 14 | |
| 17 | 2016 | 12 | |
| 18 | 2023 | 9 | |
| 19 | 2016 | 9 | |
| 20 | 2015 | 8 |
About Haloom Rafehi
Haloom Rafehi is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience, Genetics, Cancer Research and Oncology, having authored 33 papers that have together received 1.0k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (8 papers), Genetic Neurodegenerative Diseases (4 papers), Epigenetics and DNA Methylation (4 papers), Genetics and Neurodevelopmental Disorders (3 papers), Protein Degradation and Inhibitors (3 papers), Genomics and Chromatin Dynamics (3 papers), RNA modifications and cancer (2 papers) and DNA Repair Mechanisms (2 papers). The work is most often cited by research in Rehabilitation (50 citations), Molecular Biology (543 citations), Cancer Research (98 citations), Biochemistry (39 citations) and Endocrinology, Diabetes and Metabolism (89 citations). Haloom Rafehi has collaborated with scholars based in Australia, Hong Kong and China. Frequent co-authors include Assam El‐Osta, Tom C. Karagiannis, Katherine Ververis, Mark Ziemann, Christian Orlowski, Antony Kaspi, Jenny Y. Y. Ooi, Xiao‐Jun Du, Enzo R. Porrello and Mirana Ramialison. Their work appears in journals such as Epigenetics, npj Parkinson s Disease, European Journal of Human Genetics, Non-Coding RNA and Journal of Visualized Experiments.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.